EUVIMEDEUVIMED entdecken
Open Access

Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis

Lydia E Federico iD, Tate M Johnson iD, Bryant R England iD, Katherine D Wysham iD, Michael D George iD, Brian Sauer iD, Bartlett C Hamilton, Carlos D Hunter, Michael J Duryee, Geoffrey M Thiele, Ted R Mikuls iD, Joshua F Baker

Arthritis Care & Research · 2023-04 · 75 (4) · 768-777

DOI: 10.1002/acr.24885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 11.11.2022. Verfasst von Lydia E Federico und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Pennsylvania, Philadelphia. Hauptthemen laut MEDLINE: Adipokines, Arthritis, Rheumatoid, Cardiovascular Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIGMS NIH HHS, CSRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess whether circulating levels of adiponectin, leptin, and fibroblast growth factor 21 (FGF‐21) are associated with incident cardiovascular disease (CVD) in rheumatoid arthritis (RA).

Methods

Adipokines were measured using banked enrollment serum from patients with RA and dichotomized above/below the median value. Incident CVD events (coronary artery disease [CAD], stroke, heart failure [HF] hospitalization, venous thromboembolism, CVD‐related deaths) were identified using administrative data and the National Death Index. Covariates were derived from medical record, biorepository, and registry databases. Multivariable Cox models were generated to quantify associations between adipokine concentrations and CVD incidence. Five‐year incidence rates were predicted.

Results

Among 2,598 participants, 639 (25%) had at least 1 CVD event over 19,585 patient‐years of follow‐up. High adiponectin levels were independently associated with HF hospitalization (hazard ratio [HR] 1.39 [95% confidence interval (95% CI) 1.07–1.79], P = 0.01) and CVD‐related death (HR 1.49 [95% CI 1.16–1.92], P = 0.002) but not with other CVD events. High leptin was independently associated with CVD‐related death (HR 1.44 [95% CI 1.05–1.97], P = 0.02). High FGF‐21 levels were independently associated with lower rates of CAD (HR 0.75 [95% CI 0.58–0.97], P = 0.03). In subgroup analyses, associations between high adiponectin and leptin levels with CVD‐related death were driven by strong associations in nonobese patients.

Conclusion

Adipokines are associated with HF hospitalization and CVD‐related death in patients with RA, with stronger associations in nonobese participants. These findings suggest that adipokines effectively predict clinically important outcomes in RA perhaps through an association with body composition and metabolic health. Further study is needed to determine whether adipokine measures might augment existing tools to identify RA patients at increased risk of CVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdipokinesArthritis, RheumatoidCardiovascular DiseasesHumansAdiponectinCoronary Artery DiseaseLeptinRisk Factors

Substanzen

AdipokinesAdiponectinLeptin

Autor:innen und Institutionen

  • University of Pennsylvania, Philadelphia.
  • Veterans Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska.
  • Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle.
  • University of Utah Medical Center and Veterans Affairs Salt Lake City Health Care System, Salt Lake City.
  • University of Nebraska Medical Center, Omaha.
  • University of Pennsylvania and Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia.

ORCID-Profile: Lydia E Federico, Tate M Johnson, Bryant R England, Katherine D Wysham, Michael D George, Brian Sauer, Ted R Mikuls

Förderung

  • NIAMS NIH HHS
  • NIGMS NIH HHS
  • CSRD VA
  • RRD VA
  • NIAAA NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institute of General Medical Sciences
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Federico, L. E., Johnson, T. M., England, B. R., Wysham, K. D., George, M. D., Sauer, B., Hamilton, B. C., Hunter, C. D., Duryee, M. J., Thiele, G. M., Mikuls, T. R., & Baker, J. F. (2023). Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis. Arthritis Care & Research, 75(4), 768-777. https://doi.org/10.1002/acr.24885

Vancouver

Federico LE, Johnson TM, England BR, Wysham KD, George MD, Sauer B, et al. Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis. Arthritis Care & Research. 2023;75(4):768-777. doi:10.1002/acr.24885

BibTeX
@article{Federico2023,
  author = {Federico, Lydia E and Johnson, Tate M and England, Bryant R and Wysham, Katherine D and George, Michael D and Sauer, Brian and Hamilton, Bartlett C and Hunter, Carlos D and Duryee, Michael J and Thiele, Geoffrey M and Mikuls, Ted R and Baker, Joshua F},
  title = {Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis},
  journal = {Arthritis Care & Research},
  year = {2023},
  volume = {75},
  number = {4},
  pages = {768--777},
  doi = {10.1002/acr.24885}
}
Kostenlos starten →